Prevalence, predictors, and outcomes of in-stent restenosis with calcified nodules

EuroIntervention. 2022 Mar 18;17(16):1352-1361. doi: 10.4244/EIJ-D-21-00504.

Abstract

Background: Calcified nodules (CN) have been reported as being associated with stent failure including in-stent restenosis (ISR). However, there is no systematic study of this condition.

Aims: We aimed to clarify the prevalence, predictors, and midterm results of ISR lesions with CN.

Methods: We examined the clinical characteristics of 651 ISR lesions in patients who underwent percutaneous coronary intervention (PCI) with optical coherence tomography (OCT) between October 2008 and July 2016, and their 6- to 8-month follow-up angiography results. CN was defined as a high backscattering mass with small nodular calcium depositions which protruded into the vessel lumen.

Results: Thirty-two ISR lesions (4.9%) had CN. Multivariable analysis showed that calcified lesion (odds ratio [OR] 12.441, p<0.001), incomplete stent apposition (OR 3.228, p=0.005), haemodialysis (OR 3.633, p=0.024), and female gender (OR 3.212, p=0.036) were independently associated with ISR lesions with CN. Midterm follow-up was performed on 612 ISR lesions. Both ISR and target lesion revascularisation (TLR) rates were significantly higher in lesions with CN compared with those without CN (43.8% vs 25.0%, p=0.023; 37.5% vs 18.8%, p=0.020, respectively). However, multivariate analysis did not show the presence of CN as an independent predictor of re-TLR (OR 1.690, p=0.286).

Conclusions: The prevalence of ISR lesions with CN was 4.9%. Calcified lesions, incomplete stent apposition, haemodialysis, and female gender are probably associated with CN formation. ISR lesions with CN may have poor midterm outcomes compared with ISR lesions without CN.

MeSH terms

  • Coronary Angiography / methods
  • Coronary Restenosis* / epidemiology
  • Coronary Restenosis* / pathology
  • Coronary Restenosis* / therapy
  • Coronary Vessels / diagnostic imaging
  • Coronary Vessels / pathology
  • Drug-Eluting Stents*
  • Female
  • Humans
  • Male
  • Percutaneous Coronary Intervention* / adverse effects
  • Prevalence
  • Risk Factors
  • Stents / adverse effects
  • Treatment Outcome